Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease

Treatment with L-3,4-dihydroxyphenylalanine (L-Dopa) compensates for decreased striatal dopamine (DA) levels and reduces Parkinson’s disease (PD) symptoms. However, during disease progression, L-Dopa-induced dyskinesia (LID) develops virtually in all PD patients, making the control of PD symptoms di...

Celý popis

Podrobná bibliografie

Vydáno v:	NPJ Parkinson's Disease Ročník 10; číslo 1; s. 228 - 13
Hlavní autoři:	Servillo, Federica, De Carluccio, Maria, Di Lazzaro, Giulia, Campanelli, Federica, Marino, Gioia, Natale, Giuseppina, Ledonne, Ada, Massaro Cenere, Mariangela, Paldino, Emanuela, Di Giuda, Daniela, Picca, Anna, Bove, Francesco, Di Iorio, Riccardo, Angeloni, Benedetta, Cimmino, Angelo Tiziano, Bellomo, Giovanni, Picconi, Barbara, Bentivoglio, Anna Rita, Mercuri, Nicola Biagio, Parnetti, Lucilla, Ghiglieri, Veronica, Viscomi, Maria Teresa, Calabresi, Paolo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 30.11.2024 Nature Publishing Group Nature Portfolio
Témata:	631/378/2591 692/617/375/1718 Animals Biomedical and Life Sciences Biomedicine Denervation Dopamine Dyskinesia Genotype & phenotype Health risk assessment Neurology Neurosciences Physiology Risk factors
ISSN:	2373-8057, 2373-8057
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!